{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:35:20Z","timestamp":1780936520776,"version":"3.54.1"},"reference-count":26,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HemaSphere"],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:p>Supplemental Digital Content is available in the text<\/jats:p>","DOI":"10.1097\/hs9.0000000000000033","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T20:01:48Z","timestamp":1519934508000},"source":"Crossref","is-referenced-by-count":5,"title":["Identifying Educational Needs and Practice Gaps of European Hematologists and Hematology Nurses in the Treatment and Management of Multiple Myeloma"],"prefix":"10.1002","volume":"2","author":[{"given":"Suzanne","family":"Murray","sequence":"first","affiliation":[{"name":"AXDEV Group Inc. Brossard QC Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Mohty","sequence":"additional","affiliation":[{"name":"Hematology and Cellular Therapy Department Hospital St Antoine University Pierre &amp; Marie Curie Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Peloquin","sequence":"additional","affiliation":[{"name":"AXDEV Group Inc. Brossard QC Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels W.","family":"Van de Donk","sequence":"additional","affiliation":[{"name":"Department of Haematology VU University Medical Center Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Leit\u00e3o","sequence":"additional","affiliation":[{"name":"Janssen\u2010Cilag Farmac\u00eautica Barcarena Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Labb\u00e9","sequence":"additional","affiliation":[{"name":"AXDEV Group Inc. Brossard QC Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"West","sequence":"additional","affiliation":[{"name":"Haemato\u2010Oncology Unit Royal Mardsen Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Hofst\u00e4dter\u2010Thalmann","sequence":"additional","affiliation":[{"name":"Janssen\u2010Cilag Pharma GmbH Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Sonneveld","sequence":"additional","affiliation":[{"name":"Department of Haematology Erasmus MC Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,3]]},"reference":[{"key":"e_1_2_7_2_1","first-page":"36","article-title":"Therapeutic leap for multiple myeloma in 2015: unprecedented FDA Drug Approvals","volume":"9","author":"Helwick C","year":"2016","journal-title":"Am Health Drug Benefits"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12279"},{"key":"e_1_2_7_4_1","first-page":"167","article-title":"Safety of proteasome inhibitors for treatment of multiple myeloma","volume":"16","author":"Schlafer D","year":"2017","journal-title":"Expert Opin Drug Saf"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.4177"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-116129"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.313"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13537"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402551"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-016-0282-1"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.3102\/0013189X033007014"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/2345678906293042"},{"key":"e_1_2_7_13_1","unstructured":"ICC\/ESOMAR.ICC\/ESOMAR International Code on Market and Social Research.https:\/\/www.esomar.org\/uploads\/public\/knowledge\u2010and\u2010standards\/codes\u2010and\u2010guidelines\/ICCESOMAR\u2010International\u2010Code_English.pdf. Published 2016. Accessed October 2017."},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/104973239500500201"},{"key":"e_1_2_7_15_1","volume-title":"Thematic Analysis and Code Development: Transforming Qualitative Information","author":"Boyatzis R","year":"1998"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/1049732305276687"},{"key":"e_1_2_7_17_1","volume-title":"Research Design: Qualitative, Quantitative, and Mixed Approaches","author":"Creswell JW","year":"2003"},{"key":"e_1_2_7_18_1","volume-title":"Developments in Sociology","author":"Olsen WK","year":"2004"},{"key":"e_1_2_7_19_1","unstructured":"MurrayS MohtyM. PeloquinS.et al.Practice gaps and barriers to optimal management of multiple myeloma patients: results from a mixed\u2010methods study in 8 European countries. 22nd Congress European Hematology Association;2017; Madrid Spain."},{"key":"e_1_2_7_20_1","doi-asserted-by":"crossref","unstructured":"MoreauP TouzeauC. Multiple myeloma: from front\u2010line to relapsed therapies.Am Soc Clin Oncol Educ Book2015;e504\u2013e511.","DOI":"10.14694\/EdBook_AM.2015.35.e504"},{"key":"e_1_2_7_21_1","unstructured":"Pottk\u00e4mperJ J\u00e4gerI SchieferA FischerA.Exploring Germany's relationship with clinical research. Applied Clinical Trials.http:\/\/www.appliedclinicaltrialsonline.com\/exploring\u2010germanys\u2010relationship\u2010clinical\u2010research. Published August 2012. Accessed October 2017."},{"key":"e_1_2_7_22_1","unstructured":"GallagherJ.Cancer Drugs Fund To Be Restricted\u2014Says NHS. BBC news online.http:\/\/www.bbc.com\/news\/health\u201030022025. Published November 2014. Accessed October 2017."},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4465"},{"key":"e_1_2_7_24_1","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4103\/1735-9066.157845","article-title":"Challenges in nursing continuing education: a qualitative study","volume":"20","author":"Eslamian J","year":"2015","journal-title":"Iran J Nurs Midwifery Res"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874434601105010009"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.7748\/ns2013.10.28.5.37.e8046"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2015.07.006"}],"container-title":["HemaSphere"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1097\/HS9.0000000000000033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T17:57:53Z","timestamp":1719856673000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1097\/HS9.0000000000000033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["10.1097\/HS9.0000000000000033"],"URL":"https:\/\/doi.org\/10.1097\/hs9.0000000000000033","archive":["Portico"],"relation":{},"ISSN":["2572-9241","2572-9241"],"issn-type":[{"value":"2572-9241","type":"print"},{"value":"2572-9241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3]]},"article-number":"e33"}}